טוען...
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Azithromycin is a potent macrolide antibiotic with poorly understood antiinflammatory properties. Long-term use of azithromycin in patients with chronic inflammatory lung diseases, such as cystic fibrosis (CF), results in improved outcomes. Paradoxically, a recent study reported that azithromycin us...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3163956/ https://ncbi.nlm.nih.gov/pubmed/21804191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI46095 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|